FNArena Distribution Partnership With Pitt Street Research

Pitt Street Research provides issuer-sponsored equity research on companies that are publicly traded on the Australian Securities Exchange (ASX). Our firm, based in Sydney, was founded on the conviction that investors in ASX-listed companies need high quality, detailed research more than ever, but that less and less such research is available from the conventional investment banks and stockbroking firms. Our issuer-sponsored model makes that research available in a format that is easily accessible to institutional and private investors alike.

FNArena is acting in its capability of providing additional distribution and reach to institutional and retail investors worldwide. We have no involvement in Pitt Street Research’s decision making process about which companies are selected, including the frequency, timing or depth of research provided.

Research reports are provided for information purposes only. Nothing on this section should be seen as an invitation to purchase equities or any other investment instruments. Investors should always consult with a professional before making any investment decision.

The availability of research reports via this section does not preclude FNArena journalists from independently reporting on it. Neither distribution or reporting implies endorsement by FNArena.


SE1

Sensera, Combining Micro Devices And Tracking Solutions

11 Jun 2019 / Industrials

CI1

Credit Intelligence's Acquisitive Expansion Into Asia-Pac

27 May 2019 / Financial Services

MYQ

MyFiziq, Health & Fitness Linked To Smartphone Trends

23 May 2019 / Healthcare

IVX INVION LIMITED

Invion, Potential Photodynamic Therapy For Cancer Treatment

21 May 2019 / Healthcare

SW1

Swift Media, Combining Technology, Content and Advertising

30 Apr 2019 / Industrials

DCL

DomaCom, Targeting "Asset Rich, Cash Poor" Retirees

16 Apr 2019 / Financial Services

ADO

Nano-chemistry Technology To Modify Surfaces

19 Mar 2019 / Healthcare

ANR

Anatara Lifesciences' Zoetis Deal A Company Maker

14 Mar 2019 / Healthcare

NEU

Neuren Keeps Rest-of-World Rights For Trofinetide

07 Mar 2019 / Healthcare

DCL

DomaCom, Revolutionising Property Investment

12 Feb 2019 / Financial Services

< Older Posts

 

To receive an alert whenever a future report is available, enter your email below:

For questions and/or feedback:
info@fnarena.com
marc.kennis@pittstreetresearch.com
To visit researchers’ website: www.pittstreetresearch.com